Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1988 May;81(5):1419–1426. doi: 10.1172/JCI113472

Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways.

R C Strunk 1, D M Eidlen 1, R J Mason 1
PMCID: PMC442573  PMID: 2966814

Abstract

The serum complement system is a major mediator of inflammation reactions. Two of the complement proteins, the third (C3) and fifth (C5) components, are precursors of potent phlogistic molecules, C3a and C5a. C5a has potent chemotactic activity and plays an active role in pulmonary inflammation. We present evidence suggesting that several complement proteins, including C5, are synthesized locally in the lung in alveolar type II epithelial cells. Lung tissue from normal mice synthesized and secreted C5 protein similar to the C5 protein in mouse serum, whereas lung tissue from C5-deficient mice did not. Lung tissues from both normal and C5-deficient mice synthesized C3. Rat lung tissue synthesized and secreted C5, as well as C2, C4, C3, and factor B. Cultures of type II cells (95% type II cells, 5% macrophages) regularly synthesized all these proteins. In contrast, cultures of macrophages alone synthesized large amounts of C2 and factor B, and in some experiments C3 and C4, but never C5. The C5 synthesized by the rat cells was slightly larger than serum C5 (200 kD compared with 180 kD) and was not processed to the two-chain molecule seen in serum. Rat lung tissue and purified type II cells contained C5 mRNA with the same molecular mass as the C5 mRNA in rat liver and in mouse lung and liver. Human type II cells also synthesized C5, as well as C2, C4, C3, and factor B. Human pulmonary macrophages synthesized only C2, factor B, and, in some experiments, C3. Synthesis of complement proteins in cells that line the alveolar wall may provide a local source of these proteins for inflammatory responses in the lung. Local synthesis of complement proteins could be regulated independently of the synthesis in the liver.

Full text

PDF
1419

Images in this article

1422Image
on p.1422
1423Image
on p.1423
1423Image
on p.1423
1423Image
on p.1423
1423Image
on p.1423
1423Image
on p.1423
1423Image
on p.1423
1424Image
on p.1424
1424Image
on p.1424
1424Image
on p.1424
1424Image
on p.1424

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ackerman S. K., Friend P. S., Hoidal J. R., Douglas S. D. Production of C2 by human alveolar macrophages. Immunology. 1978 Aug;35(2):369–372. [PMC free article] [PubMed] [Google Scholar]
  2. Al-Adnani M. S., McGee J. O. Clq production and secretion by fibroblasts. Nature. 1976 Sep 9;263(5573):145–146. doi: 10.1038/263145a0. [DOI] [PubMed] [Google Scholar]
  3. Aviv H., Leder P. Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose. Proc Natl Acad Sci U S A. 1972 Jun;69(6):1408–1412. doi: 10.1073/pnas.69.6.1408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Beatty D. W., Davis A. E., 3rd, Cole F. S., Einstein L. P., Colten H. R. Biosynthesis of complement by human monocytes. Clin Immunol Immunopathol. 1981 Mar;18(3):334–343. doi: 10.1016/0090-1229(81)90126-4. [DOI] [PubMed] [Google Scholar]
  5. CINADER B., DUBISKI S., WARDLAW A. C. DISTRIBUTION, INHERITANCE, AND PROPERTIES OF AN ANTIGEN, MUB1, AND ITS RELATION TO HEMOLYTIC COMPLEMENT. J Exp Med. 1964 Nov 1;120:897–924. doi: 10.1084/jem.120.5.897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chirgwin J. M., Przybyla A. E., MacDonald R. J., Rutter W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979 Nov 27;18(24):5294–5299. doi: 10.1021/bi00591a005. [DOI] [PubMed] [Google Scholar]
  7. Cole F. S., Matthews W. J., Jr, Marino J. T., Gash D. J., Colten H. R. Control of complement synthesis and secretion in bronchoalveolar and peritoneal macrophages. J Immunol. 1980 Sep;125(3):1120–1124. [PubMed] [Google Scholar]
  8. Cole F. S., Matthews W. J., Jr, Rossing T. H., Gash D. J., Lichtenberg N. A., Pennington J. E. Complement biosynthesis by human bronchoalveolar macrophages. Clin Immunol Immunopathol. 1983 May;27(2):153–159. doi: 10.1016/0090-1229(83)90065-x. [DOI] [PubMed] [Google Scholar]
  9. Cole F. S., Schneeberger E. E., Lichtenberg N. A., Colten H. R. Complement biosynthesis in human breast-milk macrophages and blood monocytes. Immunology. 1982 Jun;46(2):429–441. [PMC free article] [PubMed] [Google Scholar]
  10. Colten H. R. Biosynthesis of complement. Adv Immunol. 1976;22:67–118. doi: 10.1016/s0065-2776(08)60548-9. [DOI] [PubMed] [Google Scholar]
  11. Colten H. R. Ontogeny of the human complement system: in vitro biosynthesis of individual complement components by fetal tissues. J Clin Invest. 1972 Apr;51(4):725–730. doi: 10.1172/JCI106866. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Craddock P. R., Fehr J., Brigham K. L., Kronenberg R. S., Jacob H. S. Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. N Engl J Med. 1977 Apr 7;296(14):769–774. doi: 10.1056/NEJM197704072961401. [DOI] [PubMed] [Google Scholar]
  13. Dobbs L. G., Geppert E. F., Williams M. C., Greenleaf R. D., Mason R. J. Metabolic properties and ultrastructure of alveolar type II cells isolated with elastase. Biochim Biophys Acta. 1980 Jun 23;618(3):510–523. doi: 10.1016/0005-2760(80)90270-2. [DOI] [PubMed] [Google Scholar]
  14. Dobbs L. G., Gonzalez R., Williams M. C. An improved method for isolating type II cells in high yield and purity. Am Rev Respir Dis. 1986 Jul;134(1):141–145. doi: 10.1164/arrd.1986.134.1.141. [DOI] [PubMed] [Google Scholar]
  15. Fernandez H. N., Henson P. M., Otani A., Hugli T. E. Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions. J Immunol. 1978 Jan;120(1):109–115. [PubMed] [Google Scholar]
  16. Gospodarowicz D., Ill C. Extracellular matrix and control of proliferation of vascular endothelial cells. J Clin Invest. 1980 Jun;65(6):1351–1364. doi: 10.1172/JCI109799. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Henson P. M., McCarthy K., Larsen G. L., Webster R. O., Giclas P. C., Dreisin R. B., King T. E., Shaw J. O. Complement fragments, alveolar macrophages, and alveolitis. Am J Pathol. 1979 Oct;97(1):93–110. [PMC free article] [PubMed] [Google Scholar]
  18. Kikkawa Y., Yoneda K. The type II epithelial cell of the lung. I. Method of isolation. Lab Invest. 1974 Jan;30(1):76–84. [PubMed] [Google Scholar]
  19. Kolb W. P., Kolb L. M., Wetsel R. A., Rogers W. R., Shaw J. O. Quantitation and stability of the fifth component of complement (C5) in bronchoalveolar lavage fluids obtained from non-human primates. Am Rev Respir Dis. 1981 Feb;123(2):226–231. doi: 10.1164/arrd.1981.123.2.226. [DOI] [PubMed] [Google Scholar]
  20. Larsen G. L., Mitchell B. C., Harper T. B., Henson P. M. The pulmonary response of C5 sufficient and deficient mice to Pseudomonas aeruginosa. Am Rev Respir Dis. 1982 Aug;126(2):306–311. doi: 10.1164/arrd.1982.126.2.306. [DOI] [PubMed] [Google Scholar]
  21. Larsen G. L., Mitchell B. C., Henson P. M. The pulmonary response of C5 sufficient and deficient mice to immune complexes. Am Rev Respir Dis. 1981 Apr;123(4 Pt 1):434–439. doi: 10.1164/arrd.1981.123.4.434. [DOI] [PubMed] [Google Scholar]
  22. Mason R. J., Walker S. R., Shields B. A., Henson J. E., Williams M. C. Identification of rat alveolar type II epithelial cells with a tannic acid and polychrome stain. Am Rev Respir Dis. 1985 May;131(5):786–788. doi: 10.1164/arrd.1985.131.5.786. [DOI] [PubMed] [Google Scholar]
  23. Mason R. J., Williams M. C. Type II alveolar cell. Defender of the alveolus. Am Rev Respir Dis. 1977 Jun;115(6 Pt 2):81–91. doi: 10.1164/arrd.1977.115.S.81. [DOI] [PubMed] [Google Scholar]
  24. Ooi Y. M., Colten H. R. Biosynthesis and post-synthetic modification of a precursor (pro-C5) of the fifth component of mouse complement (C5). J Immunol. 1979 Dec;123(6):2494–2498. [PubMed] [Google Scholar]
  25. Ooi Y. M., Colten H. R. Genetic defect in secretion of complement C5 in mice. Nature. 1979 Nov 8;282(5735):207–208. doi: 10.1038/282207a0. [DOI] [PubMed] [Google Scholar]
  26. Parrish D. A., Mitchell B. C., Henson P. M., Larsen G. L. Pulmonary response of fifth component of complement-sufficient and -deficient mice to hyperoxia. J Clin Invest. 1984 Sep;74(3):956–965. doi: 10.1172/JCI111515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Pennington J. E., Matthews W. J., Jr, Marino J. T., Jr, Colten H. R. Cyclophosphamide and cortisone acetate inhibit complement biosynthesis by guinea pig bronchoalveolar macrophages. J Immunol. 1979 Sep;123(3):1318–1321. [PubMed] [Google Scholar]
  28. Reid K. B., Porter R. R. The proteolytic activation systems of complement. Annu Rev Biochem. 1981;50:433–464. doi: 10.1146/annurev.bi.50.070181.002245. [DOI] [PubMed] [Google Scholar]
  29. Robinson P. C., Voelker D. R., Mason R. J. Isolation and culture of human alveolar type II epithelial cells. Characterization of their phospholipid secretion. Am Rev Respir Dis. 1984 Dec;130(6):1156–1160. doi: 10.1164/arrd.1984.130.6.1156. [DOI] [PubMed] [Google Scholar]
  30. Strunk R. C., Cole F. S., Perlmutter D. H., Colten H. R. gamma-Interferon increases expression of class III complement genes C2 and factor B in human monocytes and in murine fibroblasts transfected with human C2 and factor B genes. J Biol Chem. 1985 Dec 5;260(28):15280–15285. [PubMed] [Google Scholar]
  31. Strunk R. C., Whitehead A. S., Cole F. S. Pretranslational regulation of the synthesis of the third component of complement in human mononuclear phagocytes by the lipid A portion of lipopolysaccharide. J Clin Invest. 1985 Sep;76(3):985–990. doi: 10.1172/JCI112099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Wetsel R. A., Ogata R. T., Tack B. F. Primary structure of the fifth component of murine complement. Biochemistry. 1987 Feb 10;26(3):737–743. doi: 10.1021/bi00377a013. [DOI] [PubMed] [Google Scholar]
  33. Whaley K. Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes. J Exp Med. 1980 Mar 1;151(3):501–516. doi: 10.1084/jem.151.3.501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Wheat W. H., Wetsel R., Falus A., Tack B. F., Strunk R. C. The fifth component of complement (C5) in the mouse. Analysis of the molecular basis for deficiency. J Exp Med. 1987 May 1;165(5):1442–1447. doi: 10.1084/jem.165.5.1442. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES